Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 453 | 427 | 446 | 751 | 1,064 | 1,273 | 1,673 | 2,143 | 2,365 | 2,396 | | 2,396 |
% Growth | NA | -5.9% | 4.5% | 68.5% | 41.6% | 19.7% | 31.4% | 28.1% | 10.4% | 1.3% | | |
| | | | | | | | | | | | |
Cost of Revenue | (290) | (258) | (280) | (462) | (650) | (665) | (828) | (1,007) | (1,031) | (1,094) | | (1,094) |
Gross Profit | 163 | 168 | 166 | 289 | 413 | 608 | 845 | 1,135 | 1,334 | 1,302 | | 1,302 |
% Revenue | 35.9% | 39.4% | 37.1% | 38.5% | 38.9% | 47.8% | 50.5% | 53.0% | 56.4% | 54.3% | | 54.3% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (139) | (131) | (138) | (205) | (244) | (322) | (452) | (552) | (583) | (623) | | (623) |
Other Inc / (Exp) | (44) | (41) | (85) | (54) | (170) | (164) | (125) | (72) | (77) | (415) | | (415) |
Total Operating Exp | (184) | (171) | (224) | (259) | (414) | (486) | (577) | (624) | (660) | (1,038) | | (1,038) |
| | | | | | | | | | | | |
Operating Income | (21) | (3) | (58) | 30 | (1) | 123 | 268 | 511 | 673 | 264 | | 264 |
% Revenue | -4.6% | -0.7% | -13.1% | 4.0% | -0.1% | 9.7% | 16.0% | 23.9% | 28.5% | 11.0% | | 11.0% |
| | | | | | | | | | | | |
Interest Expense | (82) | (84) | (107) | (98) | (123) | (119) | (116) | (146) | (205) | (227) | | (227) |
Pre-tax Income | (103) | (88) | (165) | (68) | (123) | 4 | 151 | 365 | 468 | 37 | | 37 |
Earnings of Discontinued Ops. | (3) | 32 | 15 | 0 | 0 | 16 | 45 | 63 | 135 | 0 | | 0 |
Provision for Taxes | 34 | 25 | 1 | 39 | 2 | 56 | (37) | (89) | (127) | (8) | | (8) |
Net Income to Company | (72) | (31) | (150) | (30) | (121) | 75 | 160 | 340 | 476 | 28 | | 28 |
% Margin | -15.8% | -7.3% | -33.6% | -4.0% | -11.4% | 5.9% | 9.6% | 15.8% | 20.1% | 1.2% | | 1.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 2 | 5 | 0 | (1) | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | (72) | (31) | (148) | (25) | (121) | 74 | 160 | 340 | 476 | 28 | | 28 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 3 | (32) | (15) | 0 | 0 | (16) | (45) | (63) | (135) | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (69) | (63) | (162) | (25) | (121) | 58 | 115 | 276 | 342 | 28 | | 28 |
% Margin | -15.2% | -14.8% | -36.4% | -3.4% | -11.4% | 4.6% | 6.9% | 12.9% | 14.5% | 1.2% | | 1.2% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (4.74) | (4.34) | (8.22) | (0.29) | (1.11) | 0.34 | 0.51 | 1.27 | 1.72 | 0.15 | | 0.15 |
Diluted EPS (Continuing Ops) | (4.74) | (4.34) | (8.22) | (0.53) | (1.11) | 0.16 | 0.49 | 1.25 | 1.69 | 0.15 | | 0.15 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 14.55 | 14.55 | 19.76 | 87.21 | 108.68 | 169.23 | 226.52 | 216.81 | 198.55 | 188.10 | | 188.10 |
WA Diluted Shares Out. | 14.55 | 14.55 | 19.76 | 88.95 | 108.68 | 177.27 | 232.79 | 221.40 | 201.85 | 190.29 | | 190.29 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (103) | (88) | (165) | (68) | (123) | 4 | 151 | 365 | 468 | 37 | | 37 |
Addback: Net Interest Expense | 82 | 84 | 107 | 98 | 123 | 119 | 116 | 146 | 205 | 227 | | 227 |
Addback: Other Non Operating Expenses, Total | 11 | 13 | (13) | (21) | 109 | (4) | 27 | 1 | 7 | 1 | | 1 |
Addback: Depreciation & Amortization | 23 | 9 | 9 | 15 | 15 | 55 | 64 | 62 | 73 | 83 | | 83 |
Addback: Restructuring Charges | 9 | 3 | 2 | 15 | 12 | 11 | 0 | (0) | 0 | 9 | | 9 |
Addback: Merger / Acquisition Expenses | 0 | 8 | 24 | 50 | 27 | 81 | 28 | 15 | 13 | 8 | | 8 |
Addback: Goodwill Impairment | 0 | 6 | 61 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | (9) | (13) | (12) | (14) | (26) | (31) | (33) | (27) | | (27) |
Addback: Asset Writedown | 0 | 0 | 0 | 2 | 3 | 0 | 0 | 0 | 0 | 133 | | 133 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | (6) | (3) | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 9 | 42 | 6 | 0 | 0 | 180 | | 180 |
Adjusted EBITDA | 22 | 36 | 15 | 72 | 159 | 294 | 367 | 559 | 733 | 650 | | 650 |
% Margin | 4.9% | 8.4% | 3.4% | 9.6% | 14.9% | 23.1% | 22.0% | 26.1% | 31.0% | 27.1% | | 27.1% |
| | | | | | | | | | | | |
Adjusted EBIT | (0) | 27 | 6 | 57 | 144 | 239 | 303 | 497 | 660 | 567 | | 567 |
% Margin | -0.1% | 6.3% | 1.4% | 7.6% | 13.5% | 18.8% | 18.1% | 23.2% | 27.9% | 23.7% | | 23.7% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (72) | (31) | (150) | (30) | (121) | 75 | 160 | 340 | 476 | 28 | | 28 |
Addback: Unusual Items | 9 | 17 | 78 | 49 | 36 | 120 | 8 | (16) | (20) | 302 | | 302 |
Less: Tax Benefit of Unusual Items (26%) | (2) | (4) | (20) | (13) | (9) | (31) | (2) | 4 | 5 | (79) | | (79) |
Adjusted Net Income | (65) | (19) | (92) | 6 | (95) | 164 | 166 | 328 | 462 | 252 | | 252 |
% Margin | -14.3% | -4.3% | -20.7% | 0.8% | -8.9% | 12.9% | 9.9% | 15.3% | 19.5% | 10.5% | | 10.5% |